| CREB phosphorylation through the activation of CaMKII | R-HSA-442729 | 9.08 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 7.85 |
| CaM pathway | R-HSA-111997 | 8.28 |
| Ca-dependent events | R-HSA-111996 | 8.18 |
| CREB phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 10.18 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.11 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 |
| Signaling by NOTCH | R-HSA-157118 | 6.2 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.34 |
| GAB1 signalosome | R-HSA-180292 | 6.31 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.85 |
| Developmental Biology | R-HSA-1266738 | 3.48 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.63 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.47 |
| Neuronal System | R-HSA-112316 | 4.82 |
| Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | R-HSA-112314 | 5.85 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.28 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.51 |
| Activation of NMDA receptor upon glutamate binding and postsynaptic events | R-HSA-442755 | 7.7 |
| Signaling by EGFR | R-HSA-177929 | 4.59 |
| MAP kinase activation in TLR cascade | R-HSA-450294 | 7.28 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.73 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.37 |
| DAP12 interactions | R-HSA-2172127 | 4.56 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.71 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.66 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 7.37 |
| PI3K/AKT activation | R-HSA-198203 | 6.32 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 7.52 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 7.46 |
| Immune System | R-HSA-168256 | 2.37 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.37 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.62 |
| Downstream signal transduction | R-HSA-186763 | 4.65 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 9.81 |
| CREB phosphorylation through the activation of Ras | R-HSA-442742 | 8.23 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 4.95 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.08 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.73 |
| Signalling by NGF | R-HSA-166520 | 4.23 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.4 |
| MyD88-independent TLR3/TLR4 cascade | R-HSA-166166 | 6.47 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.71 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
| Innate Immune System | R-HSA-168249 | 3.17 |
| NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 |
| PLC beta mediated events | R-HSA-112043 | 7.52 |
| G-protein mediated events | R-HSA-112040 | 7.49 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.68 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.72 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 6.37 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.73 |
| Axon guidance | R-HSA-422475 | 3.93 |
| TRIF-mediated TLR3/TLR4 signaling | R-HSA-937061 | 6.47 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.51 |
| Disease | R-HSA-1643685 | 3.33 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.98 |
| CREB phosphorylation | R-HSA-199920 | 10.18 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.71 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.37 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.37 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.26 |
| Toll-Like Receptors Cascades | R-HSA-168898 | 5.91 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.59 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.56 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.56 |
| Diseases of signal transduction | R-HSA-5663202 | 4.89 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.68 |
| CREB phosphorylation through the activation of CaMKK | R-HSA-442717 | 10.98 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.37 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.71 |
| Circadian Clock | R-HSA-400253 | 7.03 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.98 |
| Opioid Signalling | R-HSA-111885 | 6.64 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.68 |
| MyD88:Mal cascade initiated on plasma membrane | R-HSA-166058 | 6.56 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.69 |
| Signaling by PDGF | R-HSA-186797 | 4.53 |
| Activated TLR4 signalling | R-HSA-166054 | 6.27 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.62 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.7 |
| Adaptive Immune System | R-HSA-1280218 | 3.19 |
| Calmodulin induced events | R-HSA-111933 | 8.28 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 11.4 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 8.89 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.37 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.43 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.4 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.69 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.69 |
| Signaling by FGFR | R-HSA-190236 | 4.67 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.73 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.9 |
| DAP12 signaling | R-HSA-2424491 | 4.64 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 9.4 |
| BMAL1:CLOCK,NPAS2 activates circadian gene expression | R-HSA-1368108 | 7.59 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.89 |
| PLC-gamma1 signalling | R-HSA-167021 | 7.89 |
| Signaling by GPCR | R-HSA-372790 | 2.68 |
| Signal Transduction | R-HSA-162582 | 1.78 |